Blood, 1960, Vol. 15, No. 5, pp. 741-747.
© 1960 American Society of Hematology, Inc.
Heparin Therapy in Autoimmune Hemolytic Anemia
WILLIAM MCFARLAND 1,
ROBERT G. GALBRAITH 1, and
AUGUST MIALE JR. 1
1 U. S. Naval Hospital, National Naval Medical Center, Bethesda, Md.
1. Although a few previous reports suggest a beneficial effect of heparin
in autoimmune hemolytic anemia, there has been no general recognition of
this form of treatment. Therefore, its striking benefit in a patient with severe
autoimmune hemolytic anemia refractory to usual therapeutic measures has
been reported.
2. The mechanism of action of heparin in autoimmune hemolytic anemia
remains unknown; it does not appear to be due to any anticomplementary
activity.
3. Heparin should be tried more widely in autoimmune hemolytic anemia,
particularly in situations in which response to corticosteroids and splenectomy
has been disappointing.